Hearing Disability is considered if the hearing loss is more than 40 dB in adults and 30dB in children from age group 0-14 years. According to the World Health Organization 2019 report the number of people suffering with hearing loss globally are 360 million which represents 5.3% of the world’s population. Low frequency sounds are sensed near the apex of cochlea and high frequency sounds near the base. Precise understanding of the ear anatomy is important to perform effective diagnosis and conclude the probable cause of hearing loss.

The test types included in the scope of the report are speech discrimination test, pure tone test, tympanometry test, speech reception threshold test, most comfortable listening level test, bone conduction test, uncomfortable loudness level test and others. By indications the hearing screening and diagnostic devices are sub segmented as conductive hearing loss, sensorineural hearing loss, combination hearing loss and others.

Market sizing and forecasting furnishes information regarding the performance of various tests and indications in different geographical regions.

The existing competition in the hearing screening and diagnostic devices could be understood by the competitive landscape. The parameters such as geographical coverage, product portfolio and inception are considered for mapping the competitive landscape. The diverse range of products available in the market for diagnosis and evaluation purpose are covered in the company profiles. Porters five forces analysis gives brief description of the business analytics of hearing screening and diagnostic devices. The outstanding manufacturers actively engaged in the production of hearing screening and diagnostic devices are Accent Hearing Pty, Ltd., GN Otometrics, Interacoustics A/S, IntriCon Corporation, MAICO Diagnostics GmbH, Nashua Hearing Group, Natus Medical Incorporated, Neurosoft, OTODYNAMICS Ltd., and Siemens Healthcare GmbH.

As per the research findings of World Health Organization, loss of hearing is the sixth largest contributor to the global burden of diseases. It has a severe negative social impact on the patients in today’s cultural environment of faster information exchange. There is rehabilitative treatment available for any kind of hearing loss provided timely and accurate diagnosis is performed. Anatomically the ear is divided in three sections the external, middle and inner ear, and the disease etiology for hearing loss involves more than one section of the ear. At present conductive hearing loss is the most widely diagnosed ear complication owing to the rising prevalence of patients suffering with cerumen impaction and otosclerosis. In addition patients suffering with severe otitis media infection later develop conductive hearing loss. Sensorineural hearing loss is on rise due to increase in loud noise exposure, inherited disorders and presbycusis.

Diagnostic devices for hearing gives evaluation of the sensitivity of a person towards hearing and severity of hearing loss. The facets that contributes towards market growth of hearing screening and diagnostic devices are increasing cases of ear trauma due to medication or toxins and rising noise pollution due to rapid urbanization. Tympanometry tests are widely utilized by the ENT surgeons to perform precise diagnosis of the middle ear. It is used for the detection of fluid and perforation in eardrums in otitis media infection. Pure tone test and bone conduction test together are gaining tremendous importance for its ability to evaluate the degree of hearing loss in patients. If the test results from both the tests are same then it is diagnosed as sensironeural loss in patients and if the results are different then patient is suffering with conductive hearing loss. The chief players that dominate the hearing screening and diagnostic devices market are Accent Hearing Pty, Ltd., GN Otometrics, Interacoustics A/S, IntriCon Corporation, MAICO Diagnostics GmbH, Nashua Hearing Group, Natus Medical Incorporated, Neurosoft, OTODYNAMICS Ltd., and Siemens Healthcare GmbH.

National Institute on Deafness and Other Communication Disorders (NIDCD) has reported that in the United States about 2 to 3 per 1000 children are born with hearing loss. Approximately 15 % of U.S. adult population aged 18 years and above report some trouble in hearing. Increasing number of citizens reporting hearing complications and presence of thriving diagnostic centers make North America the global leader in hearing screening and diagnostic devices market. In Europe the rising prevalence of inherited hearing disorders and presbycusis thrusts the hearing screening and diagnostic devices market growth. According to World Health Organization 2019 statistics approximately one thirds of people above 65 years are suffering with hearing loss in Asia Pacific region. Poor health awareness in low income families regarding cleaning the earwax has resulted in otitis media infection causing trauma to the ear drums. Competitive market created by the domestic players steer the Asian Pacific market growth.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Hearing Screening And Diagnostic Devices market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Hearing Screening And Diagnostic Devices market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Hearing Screening And Diagnostic Devices market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Hearing Screening And Diagnostic Devices market?
• Which is the largest regional market for Hearing Screening And Diagnostic Devices market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Hearing Screening And Diagnostic Devices market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Hearing Screening And Diagnostic Devices market worldwide?